nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—HBA2—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.139	0.253	CbGpPWpGaD
Mefloquine—HBA1—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.106	0.192	CbGpPWpGaD
Mefloquine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0903	0.393	CbGbCtD
Mefloquine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.085	0.371	CbGbCtD
Mefloquine—HBA2—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.0556	0.101	CbGpPWpGaD
Mefloquine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0541	0.236	CbGbCtD
Mefloquine—HBA1—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.0421	0.0766	CbGpPWpGaD
Mefloquine—HBA2—endothelium—focal segmental glomerulosclerosis	0.0375	0.393	CbGeAlD
Mefloquine—HBA2—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.0286	0.0521	CbGpPWpGaD
Mefloquine—HBA1—Effects of Nitric Oxide—NOS2—focal segmental glomerulosclerosis	0.0245	0.0445	CbGpPWpGaD
Mefloquine—HBA1—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.0217	0.0395	CbGpPWpGaD
Mefloquine—HBA2—Scavenging of heme from plasma—ALB—focal segmental glomerulosclerosis	0.0184	0.0335	CbGpPWpGaD
Mefloquine—HBA1—kidney—focal segmental glomerulosclerosis	0.0164	0.172	CbGeAlD
Mefloquine—HBA2—kidney—focal segmental glomerulosclerosis	0.0151	0.158	CbGeAlD
Mefloquine—HBA1—Scavenging of heme from plasma—ALB—focal segmental glomerulosclerosis	0.014	0.0254	CbGpPWpGaD
Mefloquine—HBA2—Binding and Uptake of Ligands by Scavenger Receptors—ALB—focal segmental glomerulosclerosis	0.00735	0.0134	CbGpPWpGaD
Mefloquine—ADORA1—kidney—focal segmental glomerulosclerosis	0.00678	0.071	CbGeAlD
Mefloquine—ADORA1—cortex of kidney—focal segmental glomerulosclerosis	0.0066	0.0692	CbGeAlD
Mefloquine—HBA1—Binding and Uptake of Ligands by Scavenger Receptors—ALB—focal segmental glomerulosclerosis	0.00557	0.0101	CbGpPWpGaD
Mefloquine—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.041	CcSEcCtD
Mefloquine—HBA1—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.00468	0.00852	CbGpPWpGaD
Mefloquine—HBA1—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.00468	0.0085	CbGpPWpGaD
Mefloquine—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00462	0.0369	CcSEcCtD
Mefloquine—HBA1—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.00381	0.00693	CbGpPWpGaD
Mefloquine—HBA1—Folate Metabolism—ALB—focal segmental glomerulosclerosis	0.0038	0.00692	CbGpPWpGaD
Mefloquine—BCHE—nephron tubule—focal segmental glomerulosclerosis	0.00377	0.0395	CbGeAlD
Mefloquine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.03	CcSEcCtD
Mefloquine—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.0277	CcSEcCtD
Mefloquine—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.0277	CcSEcCtD
Mefloquine—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.0263	CcSEcCtD
Mefloquine—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.0256	CcSEcCtD
Mefloquine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.0247	CcSEcCtD
Mefloquine—HBA1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00303	0.0055	CbGpPWpGaD
Mefloquine—HBA1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00302	0.00549	CbGpPWpGaD
Mefloquine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.0241	CcSEcCtD
Mefloquine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.0214	CcSEcCtD
Mefloquine—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.0213	CcSEcCtD
Mefloquine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.0202	CcSEcCtD
Mefloquine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.02	CcSEcCtD
Mefloquine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0188	CcSEcCtD
Mefloquine—ACHE—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00232	0.00421	CbGpPWpGaD
Mefloquine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.0181	CcSEcCtD
Mefloquine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00223	0.0234	CbGeAlD
Mefloquine—ADORA2A—Monoamine Transport—AGT—focal segmental glomerulosclerosis	0.00223	0.00405	CbGpPWpGaD
Mefloquine—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00219	0.023	CbGeAlD
Mefloquine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.0172	CcSEcCtD
Mefloquine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0169	CcSEcCtD
Mefloquine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.0148	CcSEcCtD
Mefloquine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.0145	CcSEcCtD
Mefloquine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.0144	CcSEcCtD
Mefloquine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00179	0.0188	CbGeAlD
Mefloquine—ACHE—Monoamine Transport—AGT—focal segmental glomerulosclerosis	0.00178	0.00323	CbGpPWpGaD
Mefloquine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0139	CcSEcCtD
Mefloquine—ADORA2A—HIF-2-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.00163	0.00296	CbGpPWpGaD
Mefloquine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.013	CcSEcCtD
Mefloquine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0127	CcSEcCtD
Mefloquine—ABCB1—kidney—focal segmental glomerulosclerosis	0.00158	0.0165	CbGeAlD
Mefloquine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0123	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00154	0.00279	CbGpPWpGaD
Mefloquine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0123	CcSEcCtD
Mefloquine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.00154	0.0161	CbGeAlD
Mefloquine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.012	CcSEcCtD
Mefloquine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0119	CcSEcCtD
Mefloquine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0119	CcSEcCtD
Mefloquine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0117	CcSEcCtD
Mefloquine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0116	CcSEcCtD
Mefloquine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0115	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00139	0.00252	CbGpPWpGaD
Mefloquine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0111	CcSEcCtD
Mefloquine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0109	CcSEcCtD
Mefloquine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0108	CcSEcCtD
Mefloquine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.0107	CcSEcCtD
Mefloquine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0106	CcSEcCtD
Mefloquine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0104	CcSEcCtD
Mefloquine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0103	CcSEcCtD
Mefloquine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0103	CcSEcCtD
Mefloquine—ACHE—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.00128	0.00233	CbGpPWpGaD
Mefloquine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00998	CcSEcCtD
Mefloquine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00994	CcSEcCtD
Mefloquine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00981	CcSEcCtD
Mefloquine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00981	CcSEcCtD
Mefloquine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00981	CcSEcCtD
Mefloquine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00977	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00974	CcSEcCtD
Mefloquine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00969	CcSEcCtD
Mefloquine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00948	CcSEcCtD
Mefloquine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0094	CcSEcCtD
Mefloquine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0094	CcSEcCtD
Mefloquine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00922	CcSEcCtD
Mefloquine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0092	CcSEcCtD
Mefloquine—BCHE—Peptide hormone metabolism—ACE—focal segmental glomerulosclerosis	0.00114	0.00208	CbGpPWpGaD
Mefloquine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00913	CcSEcCtD
Mefloquine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00909	CcSEcCtD
Mefloquine—ADORA1—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00108	0.00196	CbGpPWpGaD
Mefloquine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00856	CcSEcCtD
Mefloquine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0085	CcSEcCtD
Mefloquine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00844	CcSEcCtD
Mefloquine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00838	CcSEcCtD
Mefloquine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00836	CcSEcCtD
Mefloquine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00827	CcSEcCtD
Mefloquine—ADORA1—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00103	0.00187	CbGpPWpGaD
Mefloquine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00817	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00811	CcSEcCtD
Mefloquine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0081	CcSEcCtD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.001	0.00182	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000996	0.00181	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000995	0.00181	CbGpPWpGaD
Mefloquine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000969	0.00775	CcSEcCtD
Mefloquine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000962	0.00769	CcSEcCtD
Mefloquine—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00095	0.00173	CbGpPWpGaD
Mefloquine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000934	0.00747	CcSEcCtD
Mefloquine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00093	0.00743	CcSEcCtD
Mefloquine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00093	0.00743	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000915	0.00166	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000877	0.00159	CbGpPWpGaD
Mefloquine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.00693	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000859	0.00156	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—MMP2—focal segmental glomerulosclerosis	0.000854	0.00155	CbGpPWpGaD
Mefloquine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000844	0.00674	CcSEcCtD
Mefloquine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000832	0.00665	CcSEcCtD
Mefloquine—ACHE—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.000814	0.00148	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000808	0.00147	CbGpPWpGaD
Mefloquine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000805	0.00643	CcSEcCtD
Mefloquine—ADORA2A—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.000795	0.00145	CbGpPWpGaD
Mefloquine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000778	0.00622	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.000774	0.00141	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000771	0.0014	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000755	0.00137	CbGpPWpGaD
Mefloquine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000748	0.00598	CcSEcCtD
Mefloquine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000742	0.00593	CcSEcCtD
Mefloquine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000741	0.00592	CcSEcCtD
Mefloquine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00589	CcSEcCtD
Mefloquine—BCHE—Peptide hormone metabolism—AGT—focal segmental glomerulosclerosis	0.000726	0.00132	CbGpPWpGaD
Mefloquine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000699	0.00558	CcSEcCtD
Mefloquine—HBA1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000664	0.00121	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.000663	0.00121	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.000661	0.0012	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000654	0.00119	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000612	0.00111	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000608	0.0011	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000605	0.0011	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000603	0.0011	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.000595	0.00108	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000585	0.00106	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00056	0.00102	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000534	0.00097	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000522	0.00095	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—AGT—focal segmental glomerulosclerosis	0.00052	0.000945	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00051	0.000928	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00051	0.000926	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.000505	0.000919	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000503	0.000915	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000467	0.000849	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000465	0.000845	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000463	0.000841	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000461	0.000837	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000447	0.000813	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000433	0.000786	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000427	0.000776	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—ALB—focal segmental glomerulosclerosis	0.000399	0.000725	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000398	0.000724	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000396	0.00072	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000394	0.000716	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000393	0.000715	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000389	0.000706	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000372	0.000676	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00037	0.000672	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000359	0.000653	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000354	0.000644	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000349	0.000635	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000341	0.000619	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000338	0.000614	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000336	0.000611	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000333	0.000606	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000329	0.000599	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000321	0.000584	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000313	0.000569	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000311	0.000565	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000304	0.000552	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ALB—focal segmental glomerulosclerosis	0.000302	0.00055	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.0003	0.000545	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000287	0.000522	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000286	0.000519	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000284	0.000517	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000282	0.000513	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000275	0.000501	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000273	0.000497	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000271	0.000493	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00027	0.000491	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000267	0.000486	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000261	0.000474	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000259	0.000471	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000258	0.000469	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000248	0.000451	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000242	0.000441	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000241	0.000438	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00024	0.000436	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00022	0.000399	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000219	0.000398	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000218	0.000396	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—ACE—focal segmental glomerulosclerosis	0.000216	0.000393	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000209	0.000381	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000208	0.000378	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000207	0.000376	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000201	0.000366	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.0002	0.000364	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0002	0.000363	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000199	0.000362	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000198	0.000361	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000191	0.000347	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000186	0.000338	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000185	0.000337	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	0.000182	0.000331	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000182	0.00033	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000178	0.000323	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000169	0.000307	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000167	0.000303	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000163	0.000297	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000159	0.000288	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000154	0.000281	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000154	0.00028	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000154	0.000279	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000153	0.000278	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000153	0.000277	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000152	0.000276	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00014	0.000255	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000139	0.000253	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—AGT—focal segmental glomerulosclerosis	0.000137	0.000249	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000137	0.000249	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000136	0.000248	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000135	0.000246	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000134	0.000243	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000129	0.000235	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000129	0.000234	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000125	0.000228	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000125	0.000228	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000123	0.000224	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000123	0.000223	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000122	0.000221	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.00012	0.000219	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000119	0.000217	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000119	0.000216	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000118	0.000214	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000113	0.000206	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00011	0.0002	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—MMP2—focal segmental glomerulosclerosis	0.000107	0.000195	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000107	0.000195	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.99e-05	0.000182	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.92e-05	0.00018	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.69e-05	0.000176	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—LPL—focal segmental glomerulosclerosis	9.25e-05	0.000168	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.18e-05	0.000167	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	8.99e-05	0.000164	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—LPL—focal segmental glomerulosclerosis	8.5e-05	0.000155	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.29e-05	0.000151	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—LPL—focal segmental glomerulosclerosis	8.26e-05	0.00015	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.25e-05	0.00015	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AGT—focal segmental glomerulosclerosis	7.92e-05	0.000144	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.66e-05	0.000139	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AGT—focal segmental glomerulosclerosis	7.28e-05	0.000132	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AGT—focal segmental glomerulosclerosis	7.06e-05	0.000128	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	6.6e-05	0.00012	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.37e-05	0.000116	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.32e-05	0.000115	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	6.22e-05	0.000113	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—focal segmental glomerulosclerosis	6.08e-05	0.00011	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	5.81e-05	0.000106	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.65e-05	0.000103	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—focal segmental glomerulosclerosis	5.58e-05	0.000102	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	5.48e-05	9.96e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—focal segmental glomerulosclerosis	5.42e-05	9.85e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.35e-05	9.73e-05	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.21e-05	9.47e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.05e-05	9.17e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.88e-05	8.87e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.07e-05	7.39e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.03e-05	7.32e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.02e-05	7.31e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	3.8e-05	6.9e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	3.58e-05	6.51e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	3.45e-05	6.27e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.3e-05	6e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.25e-05	5.9e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.64e-05	4.81e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.49e-05	4.53e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.48e-05	4.51e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.12e-05	3.86e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.63e-05	2.96e-05	CbGpPWpGaD
